Tag: Cannara Biotech

StaffDecember 7, 2023
Daily-Hit-Header.png
BusinessDaily Hit

The Daily Hit: December 7, 2023

4min00
The Daily Hit is a recap of the top financial news stories for Dec. 7, 2023. On the Site Curaleaf Wins Uplisting to Toronto Stock Exchange New York-based Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) has won “conditional approval” from Canadian securities regulators to uplist its shares to the Toronto Stock Exchange, the company announced […]
CONTINUE READING
StaffJuly 27, 2023
Daily-Hit-Header.png
BusinessDaily Hit

The Daily Hit: July 27, 2023

5min00
The Daily Hit is a recap of the top financial news stories for July 27, 2023. On the Site Mastercard Fallout Means More Pain for Cannabis Industry When financial titan Mastercard Inc. (NYSE: MA) cut ties with a swath of payment processors that had been aiding marijuana retailers across the country, the news sent shivers […]
CONTINUE READING
StaffApril 24, 2023
daily-hit.jpg
BusinessDaily Hit

Daily Hit: April 24, 2023

5min00
The Daily Hit is a recap of the top financial news stories for April 24, 2023. On the Site SNDL Delivers Uneven Earnings: Big Revenue Gain, Big Losses SNDL Inc. (Nasdaq: SNDL) reported its earnings in Canadian dollars for the full year and fourth quarter ended Dec. 31, 2022. Net revenue for the quarter was […]
CONTINUE READING
StaffJanuary 24, 2023
daily-hit.jpg
BusinessDaily Hit

Daily Hit: January 24, 2023

4min00
The Daily Hit is a recap of the top financial news stories for January 24, 2023. On the Site FDA Releases Cannabis Industry Research Guidance The guidance document from the U.S. Food and Drug Administration follows the 2018 federal legalization of hemp via that year’s federal farm bill, which removed cannabis with less than 0.3% […]
CONTINUE READING
John SchroyerJanuary 24, 2023
Cannara.jpg
BusinessCultivationPublic

Cannara Biotech Expands, But Makes Just $2,200 in Q1 2023

2min00
Montreal-based Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB) was slightly profitable for its first financial quarter of 2023, with $2,209 in net income against $7.7 million in revenue, the company reported. The vertically integrated Canadian marijuana company also spent $2.7 million to expand its footprint, increase headcount, and bring 14 new product lines […]
CONTINUE READING
Adam JacksonNovember 28, 2022
Cannara.jpg
Business

Cannara Biotech Posts Positive Net Income With 108% Annual Revenue Rise

7min00
Canadian mega-producer Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) posted positive results that illustrate the company’s efficiency amid a crowded supply side market and pinching margins. The Québec-based operator released its fourth quarter and fiscal year 2022 financial results for the three-month and full year periods ending August 31. Cannara reported C$12 million in revenue, an […]
CONTINUE READING
Adam JacksonJuly 27, 2022
Cannara.jpg
BusinessPublic

Cannara’s Rising Profits Show Canadian Demand Remains Strong

7min00
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) posted positive third-quarter results – showing the resilience of the Québec mega-producer amid waning profits for many throughout the sector. The company announced its third-quarter financial and operating results for the three and nine-month periods ending May 31, 2022. For the key metric of quarterly revenue, Cannara saw […]
CONTINUE READING

Older Posts

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis

READ MORE
Recent Tweets
Company

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.